Feasibility of an Intervention for Somatic Flashbacks in PTSD
An Intervention for Somatic Flashbacks in Post-Traumatic Stress Disorder: a Feasibility Study
1 other identifier
interventional
15
1 country
2
Brief Summary
This trial will explore the feasibility and acceptability of an intervention for Somatic flashbacks in Post-Traumatic Stress Disorder (PTSD). Imagery Rescripting (ImRs) will form a central part of the intervention. The primary objective of this trial is to explore the acceptability and feasibility of delivering an intervention for the management of somatic flashbacks to a population of adults experiencing post-traumatic stress disorder. The secondary objectives of this trial will be to examine if the intervention leads to any differences in participants experience of somatic flashbacks and their global symptoms of PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2023
CompletedFirst Posted
Study publicly available on registry
August 18, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedJanuary 12, 2024
January 1, 2024
7 months
July 25, 2023
January 11, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Treatment Acceptability/Adherence Scale score
The Treatment Acceptability/Adherence Scale measures a participants experience of an intervention. The questionnaire is made of up 10 items and each item is measured on a scale from 1 (disagree strongly) to 7 (Agree strongly).
Through study completion, an average of 8 weeks
What percentage of participants using the service are eligible agreed to take part?
The percentage of participants who access the service who meet the eligibility criteria for the intervention
1 year
What percentage of participants who are eligible to take part, accept the intervention offer?
The percentage of participants who meet the eligibility criteria for the intervention and agree to take part in the trial.
1 year
What percentage of participants completed treatment?
The percentage of participants who agree to take part in the trial who go on to complete the intervention.
1 year
Secondary Outcomes (5)
Changes in the frequency of somatic flashbacks
Through study completion, an average of 8 weeks
Changes in the intensity of somatic flashbacks
Through study completion, an average of 8 weeks
Changes in the distress associated with somatic flashbacks
Through study completion, an average of 8 weeks
Changes in participants sense of ability to cope with the somatic flashbacks
Through study completion, an average of 8 weeks
Changes in global symptoms of PTSD
Through study completion, an average of 8 weeks
Study Arms (1)
Intervention
EXPERIMENTALImagery rescripting intervention for somatic flashback
Interventions
The current project aims to explore the feasibility of intervention featuring imagery rescripting (ImRs) and grounding in the management of somatic flashbacks amongst this population. ImRs was developed as a method to help activate a traumatic memory, bring corrective information into the memory, create a more favourable outcome to the memory and to support the participant to discover and express inhibited trauma-related emotional responses (Arntz \& Weertman, 1999).
Eligibility Criteria
You may qualify if:
- Aged 18 and above
- DSM-5 diagnosis of PTSD or Complex PTSD
- Participants who are currently experiencing somatic flashbacks
- Willing and able to provide written informed consent to treatment
You may not qualify if:
- Currently receiving another trauma-focussed intervention
- Active suicidal intent or recent (past 8 weeks) suicide attempt
- Currently abusing substances
- Participants whose participation in the study is not considered in their best interest by the clinical team at Traumatic Stress Clinic and Woodfield Trauma Service
- Participants who do not consent to the intervention sessions being recorded
- Participants who do not consent to their assessment information being made available to the trainee clinical psychologist carrying out the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University College, Londonlead
- Camden and Islington NHS Trustcollaborator
- Central and North West London NHS Foundation Trustcollaborator
Study Sites (2)
Traumatic Stress clinic
London, United Kingdom
Woodfield Trauma service
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Livia Ottisova, Doctorate
Camden and Islington NHS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2023
First Posted
August 18, 2023
Study Start
November 1, 2023
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
January 12, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share